Marta Gryniuk
Internal Medicine · Washington Court House, OHNPI 1538164595
Payments from drug & device makers
Across 219 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$653
- AstraZeneca$475
- Novo Nordisk$391
- Lilly USA, LLC$371
- Bayer$236
- Dexcom, Inc.$212
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,938100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $653 |
| AstraZeneca | 18 | $475 |
| Novo Nordisk | 27 | $391 |
| Lilly USA, LLC | 25 | $371 |
| Bayer | 13 | $236 |
| Dexcom, Inc. | 10 | $212 |
| Merck | 9 | $135 |
| Exact Sciences | 5 | $116 |
| Abbott | 6 | $114 |
| Phathom Pharmaceuticals, Inc. | 4 | $110 |
| Pfizer | 6 | $95 |
| GSK | 5 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $82 |
| Esperion Therapeutics, Inc. | 5 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Bristol Myers Squibb | 1 | $76 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Boehringer Ingelheim | 3 | $58 |
| Medtronic | 2 | $48 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Amgen | 3 | $42 |
| Astellas Pharma US Inc | 2 | $42 |
| Dynavax Technologies Corporation | 2 | $34 |
| Ironshore Pharmaceuticals Inc. | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Verona Pharma, Inc. | 1 | $26 |
| ITF Therapeutics LLC | 1 | $21 |
| Krystal Biotech Inc | 1 | $21 |
| Boston Scientific | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Lucid Diagnostics Inc. | 1 | $16 |
| Scynexis, Inc. | 1 | $16 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,938 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 134 | $103,445 |
| TrulicityDulaglutide | 95 | $97,958 |
| OzempicSemaglutide | 47 | $78,857 |
| JardianceEmpagliflozin | 49 | $50,608 |
| FarxigaDapagliflozin Propanediol | 36 | $41,895 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $38,536 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 35 | $36,484 |
| JanumetSitagliptin Phos/Metformin Hcl | 31 | $29,521 |
| JanuviaSitagliptin Phosphate | 17 | $23,797 |
| XareltoRivaroxaban | 13 | $16,217 |
| MounjaroTirzepatide | 16 | $16,133 |
| VraylarCariprazine Hcl | 11 | $14,869 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $11,910 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 74 | $10,100 |
| EntrestoSacubitril/Valsartan | 13 | $10,041 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $371 | $114,091111 claims |
| PfizerEliquis | $95 | $103,445134 claims |
| MerckJanumet Xr, Janumet, Januvia | $135 | $89,80383 claims |
| Novo NordiskOzempic | $391 | $78,85747 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat | $58 | $72,23282 claims |
| AstraZenecaFarxiga, Symbicort | $475 | $47,55859 claims |
| GSKTrelegy Ellipta | $86 | $38,53653 claims |
| AbbVieVraylar, Synthroid | $653 | $17,57934 claims |
| NovartisEntresto | $14 | $10,04113 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $16 | $2,465302 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Washington Court House
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
- Yevgeniy BukhmanCanton$3.7M
- Leela VrishabhendraCincinnati$3.4M
- Narinder SainiSpringfield$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.